TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

Rosen Law Firm is notifying Telix Pharmaceuticals investors about a securities class action lawsuit alleging false statements regarding prostate cancer therapeutic candidates and supply chain quality during February 21-August 28, 2025.

Insights
TLX   negative

The lawsuit alleges the company made materially false and misleading statements about its prostate cancer therapeutic progress and supply chain quality, suggesting potential corporate misconduct and investor harm